TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling

BACKGROUND: TLN-4601 is a structurally novel farnesylated dibenzodiazepinone discovered using Thallion's proprietary DECIPHER(® )technology, a genomics and bioinformatics platform that predicts the chemical structures of secondary metabolites based on gene sequences obtained by scanning bacteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Paul M, Boufaied, Nadia, Fiordalisi, James J, Cox, Adrienne D, Falardeau, Pierre, Der, Channing J, Gourdeau, Henriette
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990749/
https://www.ncbi.nlm.nih.gov/pubmed/21044336
http://dx.doi.org/10.1186/1750-2187-5-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990749/
https://www.ncbi.nlm.nih.gov/pubmed/21044336
http://dx.doi.org/10.1186/1750-2187-5-18

Ejemplares similares